It is our hypothesis that treatment of ovarian cancer with attenuated ΔactA/ΔinlB Listeria monocytogenes (Lm) will target the immunosuppressive tumor-associated macrophage population in the microenvironment and re-polarize these cells to a pro-inflammatory phenotype. We tested this hypothesis in the aggressive ID8-Defb29/Vegf-A model